Australien - engelsk - Department of Health (Therapeutic Goods Administration)

noumed pharmaceuticals pty ltd - sodium bicarbonate, quantity: 178.5 mg; potassium chloride, quantity: 46.6 mg; sodium chloride, quantity: 350.7 mg; macrogol 3350, quantity: 13.125 g - oral liquid, powder for - excipient ingredients: acesulfame potassium; flavour - for effective relief from constipation, treatment of chronic constipation. also effective in resolving faecal impaction, defined as refractory,constipation with faecal loading of the rectum and/or colon confirmed by physical examination of the abdomen and rectum.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

noumed pharmaceuticals pty ltd - potassium chloride, quantity: 46.6 mg; sodium chloride, quantity: 350.7 mg; macrogol 3350, quantity: 13.125 g; sodium bicarbonate, quantity: 178.5 mg - oral liquid, powder for - excipient ingredients: acesulfame potassium; flavour - for effective relief from constipation, treatment of chronic constipation. also effective in resolving faecal impaction, defined as refractory,constipation with faecal loading of the rectum and/or colon confirmed by physical examination of the abdomen and rectum.

Belgien - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - macrogol 13,125 g; potassium chloride 0,0466 g; sodium chloride 0,3507 g; sodium hydrogen carbonate 0,1785 g - powder for oral solution - 13,125 g - 351 mg - 179 mg - 47 mg - sodium chloride 350.7 mg; sodium bicarbonate 178.5 mg; potassium chloride 46.6 mg; macrogol 3350 13.125 g - macrogol, combinations

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

norgine pty ltd - sodium bicarbonate, quantity: 178.6 mg; potassium chloride, quantity: 50.2 mg; sodium chloride, quantity: 350.8 mg; macrogol 3350, quantity: 13.125 g - oral liquid, solution - excipient ingredients: purified water; sucralose; flavour - for use in adults and children over 12 years of age for effective relief from constipation and treatment of chronic constipation.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sodium bicarbonate, quantity: 89.25 mg; sodium chloride, quantity: 175.35 mg; macrogol 3350, quantity: 6562.5 mg; potassium chloride, quantity: 23.3 mg - powder, oral - excipient ingredients: acesulfame potassium - for effective relief from constipation and treatment of chronic constipation in adults and children aged 2 years and older. for resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum, or the rectum and colon, confirmed by physical examination of abdomen and rectum, in adults and children 2 years and older. for prevention of recurrence of faecal impaction in children aged 2 years and older. use in children 2 years and older should be limited to 12 weeks except under medical supervision.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sodium chloride, quantity: 175.35 mg; sodium bicarbonate, quantity: 89.25 mg; potassium chloride, quantity: 23.3 mg; macrogol 3350, quantity: 6562.5 mg - powder, oral - excipient ingredients: acesulfame potassium; flavour - for effective relief from constipation and treatment of chronic constipation in adults and children aged 2 years and older. for resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum, or the rectum and colon, confirmed by physical examination of abdomen and rectum, in adults and children 2 years and older. for prevention of recurrence of faecal impaction in children aged 2 years and older. use in children 2 years and older should be limited to 12 weeks except under medical supervision.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sodium chloride, quantity: 175.35 mg; macrogol 3350, quantity: 6562.5 mg; sodium bicarbonate, quantity: 89.25 mg; potassium chloride, quantity: 23.3 mg - powder, oral - excipient ingredients: acesulfame potassium - for effective relief from constipation and treatment of chronic constipation in adults and children aged 2 years and older. for resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum, or the rectum and colon, confirmed by physical examination of abdomen and rectum, in adults and children 2 years and older. for prevention of recurrence of faecal impaction in children aged 2 years and older. use in children 2 years and older should be limited to 12 weeks except under medical supervision.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - sodium chloride, quantity: 175.35 mg; sodium bicarbonate, quantity: 89.25 mg; potassium chloride, quantity: 23.3 mg; macrogol 3350, quantity: 6562.5 mg - powder, oral - excipient ingredients: acesulfame potassium; flavour - for effective relief from constipation and treatment of chronic constipation in adults and children aged 2 years and older. for resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum, or the rectum and colon, confirmed by physical examination of abdomen and rectum, in adults and children 2 years and older. for prevention of recurrence of faecal impaction in children aged 2 years and older. use in children 2 years and older should be limited to 12 weeks except under medical supervision.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

norgine pty ltd - sodium bicarbonate, quantity: 0.0893 g; potassium chloride, quantity: 0.0159 g; macrogol 3350, quantity: 6.563 g; sodium chloride, quantity: 0.1754 g - solution, powder for - excipient ingredients: acesulfame potassium; flavour - for effective relief of constipation in adults. for treatment of chronic constipation in adults and children aged 2 years and older. for resolving faecal impaction, defined as refractory constipation with faecal loading of the rectum, or the rectum and colon, confirmed by physical examination of abdomen and rectum, in adults and children aged 2 years and older. for prevention of recurrence of faecal impaction in children aged 2 years and older. use in children 2 years and older should be limited to 12 weeks except under medical supervision.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - sodium chloride, quantity: 175.35 mg; sodium bicarbonate, quantity: 89.25 mg; potassium chloride, quantity: 23.3 mg; macrogol 3350, quantity: 6.5625 g - powder, oral - excipient ingredients: acesulfame potassium; flavour - for the treatment of constipation, including chronic constipation, and the resolution of faecal impaction (as diagnosed by a doctor).